(index / closing price / change items /% change)

Nikkei 225 17,442.40 +17.38 +0.10%

Shanghai Composite 3,122.03 +21.54 +0.69%

S&P/ASX 200 5,290.47 0.00 0.00%

FTSE 100 6,917.14 -37.08 -0.53%

CAC 40 4,470.28 -38.98 -0.86%

Xetra DAX 10,526.16 -138.85 -1.30%

S&P 500 2,111.72 -14.43 -0.68%

Dow Jones Industrial Average 18,037.10 -105.32 -0.58%

S&P/TSX Composite 14,778.32 -8.95 -0.06%

Major U.S. stock-indexes decreased on Tuesday amid uncertainty surrounding the U.S. presidential election and tepid construction spending data. Construction spending in September unexpectedly fell, which could lead to a mild downward revision to the third-quarter economic growth estimate. Another set of data showed that while U.S. factory activity increased for the second straight month in October, a gauge of new orders slipped.

Most of Dow stocks in negative area (21 of 30). Top gainer - Chevron Corporation (CVX, +1.58%). Top loser - Pfizer Inc. (PFE, -1.88%).

Almost all S&P sectors also in negative area. Top gainer - Conglomerates (+0.4%). Top loser - Utilities (-1.2%).

At the moment:

Dow 17985.00 -77.00 -0.43%

S&P 500 2109.00 -11.00 -0.52%

Nasdaq 100 4770.00 -26.75 -0.56%

Oil 46.86 0.00 0.00%

Gold 1289.40 +16.30 +1.28%

U.S. 10yr 1.86 +0.03

U.S. stock-index futures advanced, supported by better-than-expected manufacturing activity reports from China. Investors await readings on U.S. manufacturing, for further indications of the health of the world's biggest economy before this week's Fed announcement.

Global Stocks:

Nikkei 17,442.40 +17.38 +0.10%

Hang Seng 23,147.07 +212.53 +0.93%

Shanghai 3,122.03 +21.54 +0.69%

FTSE 6,959.05 +4.83 +0.07%

CAC 4,499.31 -9.95 -0.22%

DAX 10,651.07 -13.94 -0.13%

Crude $47.04 (+0.38%)

Gold $1289.10 (+1.26%)

(company / ticker / price / change ($/%) / volume)

Upgrades:

Chevron (CVX) upgraded to Overweight from Equal-Weight at Morgan Stanley

Downgrades:

Other:

Amazon (AMZN) target raised to $953 from $877 at Axiom Capital

Alcoa (AA) initiated with a Neutral at Macquarie; target $21

Pfizer reported Q3 FY 2016 earnings of $0.61 per share (versus $0.60 in Q3 FY 2015), missing analysts' consensus estimate of $0.62.

The company's quarterly revenues amounted to $13.045 bln (+7.9% y/y), generally matching analysts' consensus estimate of $13.028 bln.

The company also issued updated guidance for FY 2016, projecting EPS of $2.38-2.43 versus analysts' consensus estimate of $2.47 (previously $2.38-2.48) and revenues of $52.0-53.0 bln versus analysts' consensus estimate of$53.15 bln (previously $51.0-53.0 bln).

PFE fell to $$30.83 (-2.78%) in pre-market trading.

European stocks finished roughly unchanged on Monday, with better-than-anticipated eurozone data serving as a pillar of support, while Spanish shares charged higher as a 10-month government impasse came to an end. IHS Markit said its manufacturing PMI for the eurozone rose to a 30-month high at 53.3, better than a 52.6 estimate from a FactSet consensus of analysts. The services PMI's nine-month high of 53.5 was ahead of a 52.4 estimate.

U.S. stocks closed lower after drifting between slight gains and losses Monday, finishing October with a loss, as stronger-than-expected consumer spending data underlined the view that the economy is growing at a steady pace, while a drop in oil prices and election uncertainty weighed on the minds of investors.

Asian markets were mixed Tuesday after the release of encouraging purchasing managers index data from China and as the Bank of Japan and Australia's central bank largely held firm on their policies. The official manufacturing PMI rose to 51.2 in October from 50.4 in September, adding to signs that the world's second-largest economy is stabilizing. China's official non-manufacturing purchasing managers index, a measure of activity outside factory gates, edged up to 54.0 in October from 53.7 in September.